Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Sep 7;15(9):1234-1236.
doi: 10.2215/CJN.11740720. Epub 2020 Aug 19.

Mycophenolate Mofetil Treatment of C3 Glomerulopathy

Yonatan Peleg  1 , Gerald B Appel
Affiliations
Editorial

Mycophenolate Mofetil Treatment of C3 Glomerulopathy

Yonatan Peleg et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: mycophenolate mofetil.

PubMed Disclaimer

Comment on

  • Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.
    Caravaca-Fontán F, Díaz-Encarnación MM, Lucientes L, Cavero T, Cabello V, Ariceta G, Quintana LF, Marco H, Barros X, Ramos N, Rodríguez-Mendiola N, Cruz S, Fernández-Juárez G, Rodríguez A, Pérez de José A, Rabasco C, Rodado R, Fernández L, Pérez Gómez V, Ávila AI, Bravo L, Lumbreras J, Allende N, Sanchez de la Nieta MD, Rodríguez E, Olea T, Melgosa M, Huerta A, Miquel R, Mon C, Fraga G, de Lorenzo A, Draibe J, Cano-Megías M, González F, Shabaka A, López-Rubio ME, Fenollosa MÁ, Martín-Penagos L, Da Silva I, Alonso Titos J, Rodríguez de Córdoba S, Goicoechea de Jorge E, Praga M; Spanish Group for the Study of Glomerular Diseases GLOSEN. Caravaca-Fontán F, et al. Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1287-1298. doi: 10.2215/CJN.15241219. Epub 2020 Aug 19. Clin J Am Soc Nephrol. 2020. PMID: 32816888 Free PMC article.

References

    1. Ahmad SB, Bomback AS: C3 glomerulopathy: Pathogenesis and treatment. Adv Chronic Kidney Dis 27: 104–110, 2020. - PubMed
    1. Smith RJH, Appel GB, Blom AM, Cook HT, D’Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM: C3 glomerulopathy—Understanding a rare complement-driven renal disease. Nat Rev Nephrol 15: 129–143, 2019. - PMC - PubMed
    1. Ravindran A, Fervenza FC, Smith RJH, Sethi S: C3 glomerulopathy associated with monoclonal Ig is a distinct subtype. Kidney Int 94: 178–186, 2018. - PMC - PubMed
    1. Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, Radhakrishnan J, Marasa M, Rosenstiel PE, Herlitz LC, Markowitz GS, D’Agati VD, Appel GB: C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy. Kidney Int 93: 977–985, 2018. - PubMed
    1. Ravindran A, Fervenza FC, Smith RJH, De Vriese AS, Sethi S: C3 glomerulopathy: Ten years’ experience at Mayo Clinic. Mayo Clin Proc 93: 991–1008, 2018. - PMC - PubMed

MeSH terms

LinkOut - more resources